AzTrials
AzTrials

Mild Traumatic Brain Injury, ConcussionNCT07466589

Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)

A study testing Stochastic Galvanic Vestibular Stimulation (sGVS) in people with Mild Traumatic Brain Injury, Concussion, run by Vivonics, Inc. at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI). Read more about this study

Who is it for?
Ages 18 to 55 years
Conditions the study is for
Mild Traumatic Brain Injury, Concussion
What is being tested?
Stochastic Galvanic Vestibular Stimulation (sGVS)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
22 Aug 2025to Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-55
  • Diagnosed with concussion, evaluated at the University of Michigan
  • Symptoms persistent greater than 4-6 weeks
  • Self-reported imbalance
  • Must be able to attend in-person session.
  • No racial/ethnic groups will be excluded, although all participants must be fluent speakers of English.

Who cannot join

  • Anyone under the age of 18 or over the age of 55
  • Presence of prior diagnosis of peripheral vestibulopathy
  • Women who are pregnant
  • Inability to complete testing (e.g., severe symptom burden, inability to stand unassisted).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Deb Demski, MUP, MSW, CCRP contact

734-647-2147

darfy@med.umich.edu

United States1 site, 1 recruiting
  • University of Michigan, Michigan Medicine

    Ann Arbor, Michigan, 48109

    Deb Demski, MUP, MSW, CCRP, 734-647-2147, darfy@med.umich.edu

    Matthew Morley, MA, 734-647-3326, morleymm@umich.edu

    Recruiting

Other trials in United States

About this study

The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI).

Read the detailed description

The VIPES system that delivers sGVS is a small wearable device that administers stimulation aiming to improve the function of a vestibular system that has been adversely affected by mild TBI, concussion. In particular VIPES is designed to provide stimulus comprising random noise in a low frequency band (0 to 5Hz maximum) below the level of perception by the subject. The VIPES system consists of the four electrodes (two behind each ear). The stimulator can deliver the stimulation in multiple directions and receive information about the amplitude delivered accounting for skin impedance. The Bertec Portable Essential's dual-balance plate balance system and the APDM Opal V2R sensor are used as reference measurement tools for assessing clinical performance.

The study to be completed is an N=32 single-arm clinical investigation, comprised of a within-subject crossover study designed to evaluate whether electrical stimulation delivered by a wearable vestibular system can improve functional performance on clinical balance and mobility assessments. All participants will complete both Timed Up and Go (TUG) and mCTSIB + COBALT performance tests under a series of stimulation conditions.

Each test session begins with a Baseline (no stimulation) trial, followed by four additional trials under different stimulation levels: 0mA (sham), 0.33mA, 0.67mA, and 1.0mA. The stimulation sequence is randomized after Baseline. Participants are blinded to stimulation level during all trials.

Participants will be recruited from the pool of patients treated at the University of Michigan - NeuroSport Clinic for mTBI. Upon passing pre-screening through chart review and via phone, interested individuals will be scheduled for a study visit that begins with obtained informed consent. Prior to beginning the testing procedures, enrolled participants will provide demographic information (age, sex/gender, race, ethnicity), have height measured, weight measured, and provide a detailed medical history, history of present illness, a list of current medications, as well as complete a post-concussion symptoms questionnaire.

The performance tests to be completed:

  1. Modified Clinical Test of Sensory Integration on Balance (mCTSIB): Tool: Bertec Portable Essential's dual-balance plate balance system Rationale: mCTSIB is a balance test commonly used to evaluate individuals of all ages post-concussion. This test protocol assesses how well an individual uses sensory input when one or more sensory systems are compromised. This protocol is commonly used to evaluate individuals post-concussion to describe static balance ability. The test will be performed for each sGVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions:
  • Standard (eyes open on firm surface)
  • Proprioception (eyes closed on firm surface)
  • Vision (eyes open on foam surface)
  • Vestibular (eye closed on foam surface)
  1. COBALT Balance Test: Tool: Bertec Portable Essential's dual-balance plate balance system Rationale: COBALT is a balance test commonly used to evaluate individuals post-concussion. This test protocol places high demand on the visual and vestibular systems that is not provided by traditional balance tests. These higher demand conditions improve sensitivity in detecting balance dysfunction in those post-concussion. The test will be performed for each sGVS currents from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments. Two trials for each of the following conditions/surfaces: On Firm Surface:
  • Head Shake - Standing on firm surface with feet apart, head movement*
  • Normal stance with headshake and eyes closed. The subject will be instructed to stand still, with hands on hips and then asked to adjust head positioning approximately 30 degrees from a center position in sync with a metronome set at 120 beats/min.
  • Participant will practice with eyes open and when ready close eyes.
  • Visual Motion Sensitivity - Visual motion sensitivity condition on firm surface.
  • The subject is instructed to stand at the center of the balance plate with feet together and both arms extended out in front with hands clasped together and the thumbs straight up. The subject is to focus on the thumbs held in front while rotating approximately 30 degrees right and left, for a total excursion of 60 degrees, in sync with the metronome set at 40 beats/min. On Foam Surface:
  • Head Shake - Standing on foam with feet apart, head movement*
  • Normal stance with head shake and eyes closed on foam. Performed with the foam pad placed on the balance plate with the same procedure and parameters as HS on firm surface described above.
  • Visual Motion Sensitivity - Visual motion sensitivity condition on foam. o Performed with the foam pad placed on the balance plate with the same procedure and parameters as VMS condition on firm surface described above.
  1. Timed up and go (TUG):

Tool: Opal V2R Sensor

Rationale: TUG is a test used to assess an individual's functional balance. It requires appropriate static and dynamic balance system integration. TUG provides a measure of functional balance integration not provided from standing balance tasks.

The test will be performed for each GVS amplitudes from 0mA (sham \& baseline) to 1 mA at 0.33 mA increments.

  • The subject starts in a seated position
  • The subject stands up upon research staff command: walks 3 meters, turns around, walks back to the chair and sits down.
  • The time stops when the patient is seated.

Participants take a break following the testing prior to repeating. Following completion of the study, participants are asked to completed a short System Usability Scale Questionnaire. The entire study visit is estimated to take about 120 minutes.

The overall aim of the study is to determine whether performance improves under active stimulation conditions when compared to sham trials. Results may inform optimal parameter selection for future efficacy-focused studies.

Being tested
Stochastic Galvanic Vestibular Stimulation (sGVS)
Keywords
mTBI, mild traumatic brain injury, concussion, balance, gait, vestibular, GVS
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stochastic Galvanic Vestibular Stimulation (sGVS)Device

    The investigational intervention is a non-invasive, wearable vestibular stimulation system that delivers subsensory electrical stimulation via surface electrodes behind the ears. Stimulation is delivered at one of four levels (0.33mA, 0.67mA, 1.0mA, and 0mA sham) during standard clinical balance and mobility assessments (TUG and BERTEC). Participants are blinded to stimulation level during each trial.

Study groups in NCT07466589
Study groupRoleWhat they receive
All Participants: Randomized Stimulation SequenceExperimentalAll participants complete all performance test types (TUG and mCTSIB + COBALT), and complete each performance test under all stimulation levels (Baseline + 0mA + 0.33mA + 0.67mA + 1.0mA). Test order and stimulation sequence are randomized.
Receives: Device: Stochastic Galvanic Vestibular Stimulation (sGVS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Postural Sway during mCTSIB Across Stimulation Conditions

    Comparison of sway area (deg/s) during mCTSIB at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).

    Measured: Performance assessed when VIPES is worn and patient is completing the testing procedure.

  2. Change in TUG Time to Completion

    Comparison of time to complete the Timed Up and Go (TUG) test (seconds) at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).

    Measured: Performance assessed when VIPES is worn and patient is completing the testing procedure.

  3. Change in Postural Sway during COBALT

    Comparison of sway area (deg/s) during COBALT at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).

    Measured: Performance assessed when VIPES is worn and patient is completing the testing procedures

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2026
  2. Study start22 Aug 2025
  3. Primary completionMar 2026 (estimated)
  4. Study completionMar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Crossover
Model description
This study uses a within-subject, crossover assignment model in which all participants experience every condition. Each subject completes testing procedures at randomized stimulation levels during testing. The subjects will complete the testing procedures TUG, mCTSIB, and COBALT, at at four randomized stimulation levels: 0mA (SHAM), 0.33mA, 0.67mA, and 1.0mA. Given this study is a repeated measures study, each subject will complete a trial of a given testing procedure at a certain stimulation level twice, and continue to do so for all other testing procedures and stimulation levels. The design allows for within-subject comparisons to randomized sham controls, across stimulation intensities in effort to enhancing sensitivity in detecting changes in performance.
Masking
None (open label)
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07466589
Sponsor's protocol ID
HUM00257686
Other IDs
HT942524C0022
Status last verified
Mar 2026
First submitted
8 Sep 2025
Last updated
12 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Stochastic Galvanic Vestibular Stimulation (sGVS) in people with Mild Traumatic Brain Injury, Concussion, run by Vivonics, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Joshua Colls, B.S. (781-373-1930 ext. 263, jcolls@vivonics.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Postural Sway during mCTSIB Across Stimulation Conditions (time frame: Performance assessed when VIPES is worn and patient is completing the testing procedure.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in